A detailed history of Brandywine Global Investment Management, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 392,118 shares of CPRX stock, worth $8.47 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
392,118
Previous 435,631 9.99%
Holding current value
$8.47 Million
Previous $6.75 Million 15.53%
% of portfolio
0.05%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$15.19 - $21.35 $660,962 - $929,002
-43,513 Reduced 9.99%
392,118 $7.8 Million
Q2 2024

Aug 14, 2024

BUY
$14.68 - $16.92 $943,160 - $1.09 Million
64,248 Added 17.3%
435,631 $6.75 Million
Q1 2024

May 13, 2024

BUY
$13.18 - $17.11 $2.54 Million - $3.3 Million
192,853 Added 108.02%
371,383 $5.92 Million
Q4 2023

Feb 09, 2024

SELL
$11.78 - $17.29 $455,638 - $668,759
-38,679 Reduced 17.81%
178,530 $3 Million
Q3 2023

Nov 13, 2023

BUY
$11.69 - $15.02 $54,943 - $70,594
4,700 Added 2.21%
217,209 $2.54 Million
Q2 2023

Aug 11, 2023

SELL
$11.5 - $18.08 $11,500 - $18,080
-1,000 Reduced 0.47%
212,509 $2.86 Million
Q3 2022

Nov 14, 2022

SELL
$7.06 - $15.52 $61,831 - $135,924
-8,758 Reduced 3.94%
213,509 $2.74 Million
Q2 2022

Aug 11, 2022

SELL
$6.23 - $8.57 $201,852 - $277,668
-32,400 Reduced 12.72%
222,267 $1.56 Million
Q4 2021

Feb 11, 2022

SELL
$5.21 - $7.45 $505,239 - $722,463
-96,975 Reduced 27.58%
254,667 $1.72 Million
Q3 2021

Nov 12, 2021

BUY
$4.85 - $6.04 $9,767 - $12,164
2,014 Added 0.58%
351,642 $1.86 Million
Q2 2021

Aug 13, 2021

SELL
$4.29 - $6.05 $18,271 - $25,766
-4,259 Reduced 1.2%
349,628 $2.01 Million
Q1 2021

May 13, 2021

SELL
$3.45 - $4.69 $11,861 - $16,124
-3,438 Reduced 0.96%
353,887 $1.63 Million
Q4 2020

Feb 10, 2021

SELL
$2.97 - $3.83 $274,294 - $353,719
-92,355 Reduced 20.54%
357,325 $1.19 Million
Q3 2020

Nov 12, 2020

BUY
$2.97 - $5.08 $323,403 - $553,161
108,890 Added 31.95%
449,680 $1.34 Million
Q2 2020

Aug 14, 2020

BUY
$3.48 - $5.05 $11,233 - $16,301
3,228 Added 0.96%
340,790 $1.58 Million
Q1 2020

May 15, 2020

BUY
$2.61 - $5.21 $5,611 - $11,201
2,150 Added 0.64%
337,562 $1.3 Million
Q4 2019

Feb 14, 2020

BUY
$3.67 - $5.7 $197,207 - $306,289
53,735 Added 19.08%
335,412 $1.27 Million
Q3 2019

Nov 14, 2019

SELL
$3.89 - $7.43 $262,166 - $500,744
-67,395 Reduced 19.31%
281,677 $1.5 Million
Q2 2019

Aug 14, 2019

BUY
$2.7 - $6.11 $366,111 - $828,497
135,597 Added 63.52%
349,072 $1.34 Million
Q1 2019

May 15, 2019

BUY
$2.11 - $5.33 $450,432 - $1.14 Million
213,475 New
213,475 $1.09 Million

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.22B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.